Cargando…
In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA)
Cannabigerol (CBG) and cannabichromene (CBC) are non-psychoactive cannabinoids that have raised increasing interest in recent years. These compounds exhibit good tolerability and low toxicity, representing promising candidates for drug repositioning. To identify novel potential therapeutic targets f...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680637/ https://www.ncbi.nlm.nih.gov/pubmed/31311157 http://dx.doi.org/10.3390/molecules24142567 |
_version_ | 1783441546063904768 |
---|---|
author | Pinzi, Luca Lherbet, Christian Baltas, Michel Pellati, Federica Rastelli, Giulio |
author_facet | Pinzi, Luca Lherbet, Christian Baltas, Michel Pellati, Federica Rastelli, Giulio |
author_sort | Pinzi, Luca |
collection | PubMed |
description | Cannabigerol (CBG) and cannabichromene (CBC) are non-psychoactive cannabinoids that have raised increasing interest in recent years. These compounds exhibit good tolerability and low toxicity, representing promising candidates for drug repositioning. To identify novel potential therapeutic targets for CBG and CBC, an integrated ligand-based and structure-based study was performed. The results of the analysis led to the identification of CBG as a low micromolar inhibitor of the Enoyl acyl carrier protein (ACP) reductase (InhA) enzyme. |
format | Online Article Text |
id | pubmed-6680637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66806372019-08-09 In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA) Pinzi, Luca Lherbet, Christian Baltas, Michel Pellati, Federica Rastelli, Giulio Molecules Article Cannabigerol (CBG) and cannabichromene (CBC) are non-psychoactive cannabinoids that have raised increasing interest in recent years. These compounds exhibit good tolerability and low toxicity, representing promising candidates for drug repositioning. To identify novel potential therapeutic targets for CBG and CBC, an integrated ligand-based and structure-based study was performed. The results of the analysis led to the identification of CBG as a low micromolar inhibitor of the Enoyl acyl carrier protein (ACP) reductase (InhA) enzyme. MDPI 2019-07-15 /pmc/articles/PMC6680637/ /pubmed/31311157 http://dx.doi.org/10.3390/molecules24142567 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pinzi, Luca Lherbet, Christian Baltas, Michel Pellati, Federica Rastelli, Giulio In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA) |
title | In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA) |
title_full | In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA) |
title_fullStr | In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA) |
title_full_unstemmed | In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA) |
title_short | In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA) |
title_sort | in silico repositioning of cannabigerol as a novel inhibitor of the enoyl acyl carrier protein (acp) reductase (inha) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680637/ https://www.ncbi.nlm.nih.gov/pubmed/31311157 http://dx.doi.org/10.3390/molecules24142567 |
work_keys_str_mv | AT pinziluca insilicorepositioningofcannabigerolasanovelinhibitoroftheenoylacylcarrierproteinacpreductaseinha AT lherbetchristian insilicorepositioningofcannabigerolasanovelinhibitoroftheenoylacylcarrierproteinacpreductaseinha AT baltasmichel insilicorepositioningofcannabigerolasanovelinhibitoroftheenoylacylcarrierproteinacpreductaseinha AT pellatifederica insilicorepositioningofcannabigerolasanovelinhibitoroftheenoylacylcarrierproteinacpreductaseinha AT rastelligiulio insilicorepositioningofcannabigerolasanovelinhibitoroftheenoylacylcarrierproteinacpreductaseinha |